A detailed history of Center Book Partners LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Center Book Partners LP holds 42,507 shares of BMY stock, worth $2.5 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
42,507
Holding current value
$2.5 Million
% of portfolio
0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $1.69 Million - $2.2 Million
42,507 New
42,507 $2.2 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $49,821 - $55,318
782 Added 11.46%
7,605 $486,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $448,339 - $508,518
6,823 New
6,823 $472,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.